Single dose offers retinal repair
Researchers from Michigan State University have identified a single-dose gene therapy that demonstrates the ability to repair damaged retinas and reverse vision loss. The therapy focuses on restoring damaged neural cells and neural networks in the retina of adult mammals, achieving an unprecedented scientific breakthrough. It represents an important step toward treating eye diseases related to retinal damage.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)